Skip to main content

Digital Health Framework

Thai FDA · MDCD · Medical Device Act B.E. 2562 · ASEAN AMDD SaMD

Overview

Thailand's Medical Device Act B.E. 2562 (2019) explicitly includes software within the medical device definition. Thai FDA/MDCD applies the ASEAN AMDD framework to classify and regulate software, aligned with IMDRF principles for Software as a Medical Device (SaMD).

Regulatory Basis

InstrumentRelevance
Medical Device Act B.E. 2562 (2019)Software included in medical device definition
ASEAN AMDDSaMD classification framework adopted
IMDRF SaMD N41 (2017)International SaMD classification principles
IEC 62304Software lifecycle standard expected in CSDT
MoPH NotificationsSpecific classification and labelling rules

What Is a Medical Device Software in Thailand?

Software qualifies as a medical device when it has a medical purpose — diagnosis, prevention, monitoring, prediction, prognosis, treatment, or alleviation of disease or injury. Classification of SaMD in Thailand follows the ASEAN AMDD four-class framework. See SaMD, Combination Products & Special Classifications for the full classification matrix.

Software TypeMedical Device?Typical Class
AI diagnostic imaging analysisYesClass 3 or 4
Clinical decision support (drives treatment)YesClass 2–4 depending on severity
Remote patient monitoring with alertsYesClass 2 or 3
Drug dosing calculation (clinical output)YesClass 2 or 3
General wellness / fitness appsNo
Hospital administrative software (EMR, scheduling)No
Telemedicine video platform (no clinical output)No

Approval Pathways for SaMD

SaMD follows the standard Thai FDA pathway based on its class:

SaMD ClassPathwayKey Requirement
Class 1ListingSimple notification; auto-approved since January 2025
Class 2–3NotificationFull CSDT with software documentation (IEC 62304, V&V)
Class 4LicenseComprehensive CSDT; most stringent clinical and software evidence

Technical Documentation for SaMD

In addition to standard CSDT sections, SaMD submissions must include software-specific documentation:

DocumentStandard/Reference
Software description and intended medical purpose
Software Development Lifecycle documentationIEC 62304
Software requirements specification
Software architecture documentation
Verification and validation test reports
Usability engineering fileIEC 62366-1
Cybersecurity documentationIMDRF N60 / IEC 81001-5-1
Algorithm validation (AI/ML)IMDRF AI/ML guidance
Risk management (software hazards)ISO 14971
Post-market software update management plan

AI and Machine Learning

AI/ML software for medical purposes in Thailand is regulated as SaMD. Key considerations:

  • Training data transparency: Document data sets used — representativeness of Thai and Southeast Asian patient populations is relevant
  • Algorithm validation: Validate on independent datasets; report sensitivity, specificity, and applicable performance metrics
  • Adaptive algorithms: Software that learns post-deployment may create change management obligations — define acceptable performance boundaries in the technical documentation
  • Clinical evidence: High-risk AI tools (Class 3–4) require clinical validation data

Cybersecurity Requirements

Connected SaMD must address cybersecurity risks aligned with IMDRF N60 — Principles and Practices for Medical Device Cybersecurity:

RequirementDescription
Threat modellingIdentify attack vectors and adversaries
Secure architectureAuthentication, access control, encryption
Vulnerability managementProcess for receiving, assessing, and responding to vulnerabilities
Software update mechanismSecure delivery and installation of updates
Post-market monitoringOngoing monitoring for newly discovered vulnerabilities

Wireless Devices — NBTC Approval

SaMD that communicates wirelessly (Wi-Fi, Bluetooth, LTE/5G, NFC) requires NBTC (National Broadcasting and Telecommunications Commission) type approval in addition to Thai FDA registration. These are separate processes — ensure NBTC approval is obtained before commercial distribution. See NBTC Approval for Wireless Devices.

Post-Market Update Management

Software updates after Thai FDA approval require careful management:

  • Critical safety patches: Notify MDCD and follow FSCA procedures where the update addresses a safety issue
  • Significant changes (new indications, new features that extend intended use): Submit a variation application before release
  • Minor bug fixes with no change to safety or performance: Document and maintain records; no variation typically required

Monitor MDCD guidance for specific update notification thresholds, which are expected to be clarified as Thailand's SaMD framework matures.